Latest Breaking News On - New trials mini symposium - Page 1 : comparemela.com

Data from Apnimed’s MARIPOSA phase 2b trial of its drug candidate for OSA will be featured at the ATS 2023 International Conference.

United statesLarry millerPaula schweitzerHuy phoResearch centerInternational conferenceWaltere washington convention centerDrug administrationAmerican thoracic societyHoral agentSubjective outcomesObstructive sleep apneaControlled clinicalBreaking newsNew approachesNew trials mini symposium